Cargando…
Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre
INTRODUCTION: Drug survival is an indirect measure of efficacy and safety and its post-marketing assessment using real-life data is invaluable. OBJECTIVES: To investigate the survival of apremilast in a cohort of psoriasis patients treated with apremilast in a Greek hospital. METHODS: A retrospectiv...
Autores principales: | Sotiriou, Elena, Tsentemeidou, Aikaterini, Sideris, Nikolaos, Lallas, Aimilios, Kougkas, Nikolaos, Ioannides, Dimitrios, Vakirlis, Efstratios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116518/ https://www.ncbi.nlm.nih.gov/pubmed/35646455 http://dx.doi.org/10.5826/dpc.1202a76 |
Ejemplares similares
-
Apremilast in Psoriasis Patients With Serious Comorbidities: a Case Series and Systematic Review of Literature
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022) -
Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022) -
Under Development JAK Inhibitors for Dermatologic Diseases
por: Sideris, Nikolaos, et al.
Publicado: (2020) -
Scabies escaping detection until dermoscopy was applied
por: Lallas, Aimilios, et al.
Publicado: (2017) -
New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature
por: Sideris, Nikolaos, et al.
Publicado: (2022)